Interaction thermodynamics between warfarin, a very popular anticoagulant, and Sudlow I binding site of human (HSA) or bovine (BSA) serum albumin have been examined in strictly controlled experimental conditions (HEPES buffer 50 mM, pH 7.4 and 25 ºC) by means of isothermal titration calorimetry (ITC), fluorescence spectrometry (FS) and frontal analysis capillary electrophoresis (FA/CE). Each technique is based on measurements of a different property of the biochemical system, and then the results allow a critical discussion about the suitability of each approach to estimate the drug-protein binding parameters. The strongest interaction step is properly evaluated by the three assayed approaches being the derived binding constants strongly consistent: from 4x10 4 to 7x10 4 for HSA and from 0.8x10 5 to 1.2x10 5 for BSA. Binding enthalpy variations also show consistent results: -5.4 and -5.6 Kcal mol -1 for HSA and -4.3 and -3.7 Kcal mol -1 for BSA, as measured by ITC and FS, respectively. Further high order interaction events for both albumins are detected only by FA/CE.
Introduction
3 domain I. Warfarin has been used in studies about displacement reactions for a variety of albumin-friendly 28 drugs. Nevertheless, to interpret rightly the results, it is convenient to know precisely the binding parameters 29 of warfarin itself with albumin. Literature values about stoichiometry and energetics of warfarin interactions 30 with HSA or BSA at physiological pH are summarized in Table 1 . 31
The aim of this work is to establish reliable binding profiles of warfarin with HSA and BSA, in environments 32 close to the physiological ones. Several common techniques and strictly controlled experimental conditions 33 have been chosen to contrast efficiently the binding values derived from each approach. Thus, isothermal 34 titration calorimetry (ITC), fluorescence spectrometry (FS), and frontal analysis capillary electrophoresis 35 (FA/CE) have been selected. As well known, ITC is able to measure directly the energy and it is, in some sense, 36 the reference approach. By contrast, FS is focused on the quenching effect of drug on the protein intrinsic 37 fluorescence whereas FA/CE is based in the estimation of the bonded drug and total protein concentrations 38 ratio when electrophoretic mobility of the protein equals that of the drug-protein complex. Thus, the two 39 last approaches allow the determination of stoichiometry and binding constant as significant interaction 40 parameters. Selected techniques show different sensitivity limits and, then, not all of them are able to 41 measure properly hypothetical successive binding steps [11, 12] . Consequently, a critical comparison about 42 the binding parameters achieved by the tested techniques on a relatively simple biological interaction (just a 43 well-known acidic drug binding, mainly, the Sudlow I site of native albumin), using albumin of two biological 44 origins (HSA and BSA), in strictly controlled conditions (HEPES buffer, pH=7.4, I=50 mM, T=25 ºC) is 45 performed. Results and conclusions of this work should facilitate further studies in which warfarin is involved, 46 such as its displacement by other drugs with higher affinity with the albumin. Albumin and warfarin were solved with HEPES buffer solution. Both HSA and BSA solutions were in the 0.01 83 to 0.02 mM range, and the concentration of drug solutions varied from 0.2 to 0.5 mM. Prior to their use, all 84 solutions were degassed for a period of 5 min at 24 ºC. Titrations were performed at 25.0±0.2 ˚C. The power 85 reference was 10 µcal s -1 and the stirring rate was 290 rpm to ensure rapid mixing. The injection volume was 86 8 µL and the interval between injections was 240 s to warrant the equilibrium in each titration point. Each 87 titration involved 29 independent titrant additions. The syringe was filled with the warfarin solution whereas 88 the albumin was in the cell. Background titrations were performed according to: a) identical titrant solution 89 with the cell filled just with the buffer and b) successive buffer additions to the albumin solutions. These 90 measurements allow the determination of the background heat to be subtracted to the main titrations. 91 First, the emission spectra of warfarin (30 M in HEPES or PBS buffer, excitation wavelength: 315 nm), HSA 111 (5 M in HEPES or PBS buffer, excitation wavelength: 284 nm) and BSA (5 M in HEPES or PBS buffer, 112 excitation wavelength: 287 nm) were recorded. Warfarin, HSA and BSA showed maximum emission signals 113 at 392 nm, 344 nm, and 346, respectively. To avoid warfarin interference in HSA and BSA fluorescence 114 quenching evaluation, measurements were done using the Synchronous mode at =20 nm (em=284 nm for 115 HSA and 287 nm for BSA). Then, the linear range of HSA and BSA fluorescence was evaluated. In working 116 conditions, the linear range for both albumins was between 0.5 and 8 µM. Therefore, 5 µM HSA or BSA was 117 the chosen concentration. 118
Quenching studies were carried out by titration. The albumin (5 M, 3 mL) was placed in the cuvette and the 119 solution was taken up to the temperature under study (18, 25, 30 or 37 ± 1 ºC) using a water bath and a 120 magnetic stirrer. The initial fluorescence synchronous spectrum was recorded. Nine successive additions of 121 warfarin (312.5 M in HEPES or PBS buffer, 7 L) and five new additions of warfarin (625 M in HEPES or PBS 122 buffer; 5, 8, 11, 14 and 17 L) were done. After each addition, the solution in the cuvette was stirred (3 min, 123 900 rpm) to allow the temperature equilibration and the reaction happening. Finally, the fluorescence was 124 measured in the synchronous mode. Before first use, any new capillary was conditioned as follows: 10 min with water, 20 min with 1.0 M NaOH, 161 5 min with water, 10 min with 0.1 M NaOH, 5 min with water and, finally, 20 min with the running buffer. 162
water and 20 min with the running buffer. Finally, between runs the rinsing sequence was 1 min of water, 2 164 min of 0.1 M NaOH, and 3 min with the running buffer. At the end of the working session, the capillary was 165 rinsed again with water for 10 min. 166 HEPES buffer was used as the separation solution. Calibration curve was built from free warfarin solutions 167 Table 1 compiles literature values for warfarin interactions with both albumins, HSA and BSA, derived from a 188 variety of approaches performed in similar experimental conditions. The whole pool of values shows that 9 some works report just one drug-protein binding event but some others split the global interaction into two 190 consecutive steps. The first group involves the measurements made by ITC or FS, that is, by analytical tools 191 able to measure efficiently from moderate to high affinity events. By contrast, the works included in the 192 second group were performed by any of two separation techniques, CE/FA or equilibrium dialysis (ED), which 193 are able to evaluate properly weak and moderate binding interactions involved. It was concluded that a suitable combination of these complementary techniques could lead to 199 reliable binding profiles [12] . Table 1 shows also that the stronger binding event (or the unique one) implies, 200 in many instances, a binding constant value around 10 5 for both albumins. Reported stoichiometry is close 201 to the unity with the exception of the ITC results for warfarin-BSA interaction, which is much higher [9] . In all 202 two-step binding reports, the differences between the consecutive binding constant values are between one 203 and two orders of magnitude and the calculated stoichiometry for the second event ranges between 2 and 204 3. These data point out a relatively strong specific interaction of warfarin with both albumins and additional 205 interactions associated to weaker binding episodes. 206 Table 1 shows also that almost all literature studies were done in phosphate buffer (PBS). However, 207 phosphate, as well as citrate, borate and succinate, have some disadvantages for studies of biological or 208 complex systems. Thus, PBS has a poor buffering capacity above pH 7.5 since its dissociation constant is about 209 6.8 at plasmatic ionic strength and, in addition, it is an active participant in many biochemical processes, 210 To get the best working conditions, several titrations with different concentration ratios between warfarin 221 and HSA or BSA have been tested. The poor aqueous solubility of warfarin has compelled to select much 222 diluted solutions being the best titration curves those with an initial drug-albumin ratio about 17 for HSA 223 titrations and 20 for BSA titrations, shown in Figure 1 . In both instances, calorimetric curves show an enthalpy 224 gap between the end of the jump and the blank signal, which suggests additional warfarin-albumin 225 interactions. Derived binding parameters are gathered in Table 2 . Table 1 . 238
Only one literature reference is devoted to ITC determination of warfarin-BSA interaction but no associated 239 enthalpy datum is stated. Surprisingly, it reports a very high stoichiometry value. The authors claim that the 240 raw data seem to point out that the drug binds to albumin at more than one binding site and conclude that 241 warfarin-BSA is not a good model system for protein-ligand interactions [9] . Titrations made in this work also 242 point out high stoichiometry and a binding constant somewhat higher than the reported value.
FS measurements 245
The in-house fluorescence measurements were performed at various temperatures and fitted to Volmer relationships in order to estimate the KSV values (Eq. 1). The results, gathered in Table 3 , allow the 247 verification of the static character of the warfarin quenching effect on albumin fluorescence [19] . Therefore, 248 interaction parameters can be calculated by means of the most common approach, Eq. 2, despite it involves 249 the statement that free and total drug concentrations are equivalent. To overcome this simplifying 250 assumption and to get a more precise calculation tool, a new expression has been derived in this work (Eq. 251 3, Appendix A). It also assumes the protein as the only fluorophore agent in the biological system but it 252 embodies the free drug concentration. Experimental data for interactions of warfarin with both albumins, 253 HSA and BSA, were fitted to Eq. 3 and the results are shown in Table 2 . 254
Literature binding parameters for warfarin-HSA interaction were measured in PBS buffer at various ionic 255 strength levels. Kb values derived from solutions with high NaCl contents are about 3x10 5 and reported 256 stoichiometry ranges between 0.5 and 1.4, see Table 1 . It should be noticed the decrease in Kb and n values 257 with the increase of the NaCl content, as stated in the systematic Bolel's study [20] . This behavior can be 258 explained since chloride anions present in the solution compete with warfarin resulting in a decrease in 259 estimated warfarin-albumin binding constant [21, 22] . Despite NaCl addition to buffer solutions is not 260 mentioned in a couple of literature reports [10,23], the buffer preparation itself requires non-negligible HCl 261 amount if the very common Na2HPO4 is the main chemical used. Unfortunately, detailed buffer preparation 262 is not described in the original manuscripts. Results from this work (HEPES buffer 50 mM and chloride about 263 30 mM) show a stoichiometry close to the unity but a binding constant which is almost one order of 264 magnitude lower than most values previously published. This result could be attributed to the used fitting 265 model (Eq. 3) since slightly higher binding quantities were obtained when the same experimental data pool 266 was fitted to the common Eq. 2 (n=1.0; Kb=8.2x10 4 ). The recalculated Kb remains, however, somewhat lower 267 than most values displayed in Table 1 showing that used background solutions must be considered in 268 comparative studies. To verify again the working solution effect, Table 2 also includes the in-house results achieved in this work show an equimolar drug-protein interaction and a binding constant strongly consistent 271 with the value attained by ITC in identical working conditions. 272
Literature data for warfarin-BSA interaction show a similar behavior. Thus Kb value evaluated from FS 273 measurements in buffered solutions with a high content of NaCl is lower than the one obtained in plain 274 buffer, see Table 1 . Our own measurements lead to a binding constant value consistent with that reported 275 by Poor [2] and, such as in warfarin-HSA instance, when Eq. 2 was used slightly higher binding parameters 276 were obtained (n=1.1; Kb=3.0x10 5 ). To evaluate again the combined effect of buffer and chloride ions, new 277 measurements in PBS buffer were performed. As expected calculated binding constant is about five times 278 the one obtained in HEPES buffer, revealing again the significant role of the working solution composition, 279 see Table 2 . Table 2,  283 showing the consistency achieved from both ITC and FS approaches. 284 285 3.1.3 FA/CE measurements 286 Table 1 shows two distinct binding steps for warfarin-albumin interaction when measured by any separation 287 technique. Working temperature was 25 or 37 ºC but no significant differences in final results were reported. 288
Warfarin-HSA interaction plot measured in HEPES buffer is shown in Figure 2A . It suggests two successive 289 steps that were verified by means of the Scatchard and Klotz linear approaches. Experimental data were 290 adjusted to Eq. 5 and derived parameters indicate very similar binding constants for both binding episodes, 291 see Table 2 . The high stoichiometry value for the first one and the similarity between both binding constants 292 suggest some overlap between both steps in working conditions. Thus, results show the lower differentiating 293 ability of HEPES irrespective PBS buffer (see Table 1 ) pointing out, however, the presence of higher order 294 binding events, which are common when a charged species tents to interact with a poly-charged protein [12] . 295 Figure 2B depicted the binding curve for warfarin-BSA. Data were treated in the same way explained for HSA 296 and binding parameters of successive episodes were calculated and included in Table 2 . Values related to the 297 first binding step are consistent with literature whereas Kb for the second one is somewhat higher than those 298 previously published, see Tables 1 and 2.  299   300 3.2 Some remarks about the binding results 301
Despite the diversity among the evaluated quantities by the used analytical tools (ITC, FS and FA/CE), binding 302 constant values determined in HEPES buffer for warfarin-albumin first interaction event is strongly consistent 303 for both tested albumins, HSA or BSA. Nevertheless, the drug/protein ratio is the unity when measured by FS 304
whereas results from ITC lead to a binding stoichiometry slightly higher than the unity for HSA and twice than 305 expected for BSA. These last values can be attributed to some contribution of high order interactions clearly 306 shown by FA/CE, the only approach able to detect two distinct binding episodes for studied systems. The 307 same reason could explain the stoichiometry higher than the unity for the first binding events measured by 308 FA/CE. To evaluate properly these results, it should be taken into account that binding affinity values 309 obtained by FS just took in consideration the location of fluorophores since such technique simply measures 310 the local changes around them whereas the calorimetric approach considers the overall global changes [22] . 311 CE/FA also measures the global interaction because the mobility of the entire species is involved in 312 calculations. Nevertheless, Kb values evaluated by the three selected approaches are consistent (Table 2) and 313 all tested techniques should be considered suitable tools to solve the problem in hand. 314
In summary, at least two distinct binding events are involved in studied interactions. First episode binding 315 constants are robust being the value for warfarin-HSA about one half order of magnitude lower than that of 316 warfarin-BSA (Table 2) . Higher order binding events involve similar energy in both instances. 317
Since this work is performed in HEPES buffer and most literature binding values have been derived from PBS 318 buffered solutions, a comment about the buffer effect on binding parameter values seems to be appropriate. 319
Then, regarding warfarin-HSA first interaction, ITC results obtained from both buffered solutions agree, 320
whereas binding values from PBS solutions are about one order of magnitude higher than those obtained 321 from HEPES buffer when FS or FA/CE were used. By contrast, values obtained for warfarin-BSA interaction in successive binding events than HEPES buffer. Thus, background solution significantly affects the binding 324 parameters and should be considered in further biological studies. 325 
